@kmart_fit's TRT claims, fact-checked

What does this Instagram post actually claim?

@kmart_fit argues that TRT isn't just about muscle building but is a "lifesaving tool" for men with low testosterone. He claims it brings testosterone levels to "high-normal range" so the body can function properly, with fat loss and muscle gain being secondary benefits.

The post positions TRT as medical treatment rather than performance enhancement. This framing matters because it affects how people think about the therapy's risks and benefits.

Is TRT actually "lifesaving" for low testosterone?

No, and this is where @kmart_fit oversells the treatment. The TTrials (Snyder et al., NEJM, 2016) found that testosterone therapy improved sexual function and mood in men over 65 with low testosterone, but didn't demonstrate mortality benefits.

Low testosterone (hypogonadism) causes fatigue, reduced libido, and mood changes. These symptoms significantly impact quality of life, but they're rarely life-threatening. The FDA hasn't approved testosterone therapy for age-related testosterone decline, only for men with clinical hypogonadism.

Most men seeking TRT have borderline-low levels (250-350 ng/dL) rather than true hypogonadism (below 300 ng/dL). That's an important distinction he doesn't make.

Does TRT really target "high-normal" testosterone levels?

This claim is mostly accurate for legitimate medical treatment. The Endocrine Society guidelines recommend targeting testosterone levels between 400-700 ng/dL for hypogonadal men, which falls in the normal range.

However, many TRT clinics push levels much higher. A 2019 study in JAMA Internal Medicine found that 25% of men receiving testosterone had levels above 1000 ng/dL, well beyond normal ranges.

@kmart_fit doesn't mention this widespread practice of supraphysiologic dosing. Many online TRT providers specifically market "optimization" rather than replacement, aiming for the top 10% of normal ranges.

What about the muscle and fat loss claims?

He's right that these are secondary benefits, but understates them. The TTrials found that testosterone therapy increased lean body mass by 1.9 kg and reduced fat mass by 0.9 kg over one year in older men.

For younger men with normal baseline testosterone, the effects are more dramatic. Bhasin et al.'s landmark NEJM study (1996) showed that 600mg weekly testosterone (higher than replacement doses) increased muscle mass by 6.1 kg in 20 weeks.

The muscle-building effects are real and significant. Downplaying them seems disingenuous when that's often the primary motivation for seeking treatment.

What are the actual risks he doesn't mention?

@kmart_fit ignores the cardiovascular controversy entirely. The FDA added warnings about heart attack and stroke risks to testosterone products in 2015 after observational studies suggested increased cardiovascular events.

The TRAVERSE trial (Lincoff et al., NEJM, 2023) recently found no increased cardiovascular risk in men with hypogonadism and elevated cardiovascular risk. But this study excluded healthy younger men who make up much of the TRT market.

Other risks include sleep apnea worsening, prostate enlargement, and suppression of natural testosterone production. Men on TRT often become dependent on treatment because their natural production shuts down.